Cost-effectiveness frameworks for comparing genome and exome sequencing versus conventional diagnostic pathways: A scoping review and recommended methods-Reference-Cited by-同舟云学术

Cost-effectiveness frameworks for comparing genome and exome sequencing versus conventional diagnostic pathways: A scoping review and recommended methods

Published:2022-10 Issue:10 Volume:24 Page:2014-2027
ISSN:1098-3600
Container-title:Genetics in Medicine
language:en
Short-container-title:Genetics in Medicine

Author:

Ferket Bart S.^ORCID,Baldwin Zach,Murali Priyanka,Pai Akila,Mittendorf Kathleen F.,Russell Heidi V.,Chen Flavia,Lynch Frances L.,Lich Kristen Hassmiller,Hindorff Lucia A.,Savich Renate,Slavotinek Anne,Smith Hadley Stevens,Gelb Bruce D.,Veenstra David L.

Funder

National Cancer Institute

National Institute on Minority Health and Health Disparities

Foundation Medicine

National Human Genome Research Institute

National Institutes of Health

Publisher

Elsevier BV

Subject

Genetics (clinical)

Reference43 articles.

1. The clinical utility of exome and genome sequencing across clinical indications: a systematic review;Shickh;Hum Genet,2021